Supplementary Figure 2: Comparison between exome and targeted sequencing. | Nature Genetics

Supplementary Figure 2: Comparison between exome and targeted sequencing.

From: Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway

Supplementary Figure 2

(a) The samples included in the exome and targeted sequencing are shown in a Venn diagram. In total, 57 samples were utilized in this study, 26 of which were processed with both exome and targeted sequencing. (b) In the 26 overlapped samples, somatic non-silent mutations found in the shared coding region of exome and targeted sequencing are compared and shown in a Venn diagram. Seventy-one somatic mutations were identified by both methods; 22 and 96 were discovered only by exome or targeted sequencing, respectively.

Back to article page